1501 — Shanghai INT Medical Instruments Co Balance Sheet
0.000.00%
- HK$5.28bn
- HK$5.46bn
- CNY851.95m
- 77
- 23
- 85
- 70
Annual balance sheet for Shanghai INT Medical Instruments Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 942 | 641 | 528 | 435 | 555 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 24.2 | 79.6 | 74.1 | 125 | 119 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,048 | 858 | 802 | 724 | 892 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 300 | 565 | 750 | 898 | 917 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,423 | 1,622 | 1,827 | 2,030 | 2,260 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 88.3 | 153 | 240 | 317 | 434 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 117 | 226 | 315 | 380 | 486 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 1,306 | 1,395 | 1,512 | 1,649 | 1,774 |
| Total Liabilities & Shareholders' Equity | 1,423 | 1,622 | 1,827 | 2,030 | 2,260 |
| Total Common Shares Outstanding |